WikiDrug / Manufacturers / Lonza AG

Lonza AG

1 published medicine associated with this manufacturer.

MedicineActive ingredientDosage formStrength
Darzalex daratumumab and hyaluronidase-fihj ) Injection 1,800 mg daratumumab and 30,000 units hyaluronidase per 15 mL